Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniae. [electronic resource]
- Clinical therapeutics Dec 2010
- 2198-206 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1879-114X
10.1016/S0149-2918(11)00023-3 doi
Acetamides--administration & dosage Anti-Bacterial Agents--administration & dosage Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Drug Resistance, Multiple, Bacterial--drug effects Humans Linezolid Oxazolidinones--administration & dosage Pneumococcal Infections--drug therapy Pneumonia, Bacterial--drug therapy Retrospective Studies Treatment Outcome